Industry News
News & Articles
25
Selected Filters:
Editorial Article
Knockout validation: Confirming antibody specificity
Industry News
Abcam acquires gene-editing platform and oncology product portfolio from US biotech Applied StemCell
Transaction adds comprehensive cell editing capabilities and engine to support expansion of Abcam’s existing portfolio of ‘off-the-shelf’ edited cell lines
Industry News
Engineered knockout cell lysates for reproducible proteomic analysis
Abcam's new offering enables proteomic studies by providing
Product News
Abcam and BrickBio announce partnership to incorporate conjugation-ready sites into antibodies
The technology allows for the placement of unnatural amino acids into recombinant antibodies at specific sites
Industry News
Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knockout Cell Lines and Lysates Portfolio
The off-the-shelf diploid library includes over 2,800 single clonal knockout (KO) cell lines, targeting over 2,600 genes
Industry News
Abcam to Develop Bespoke Antibodies in New Partnership with Nanostring
Partnership will develop conjugated FFPE IHC validated antibodies that are compatible with the GeoMx Digital Spatial Profiler
Product News
Abcam plc Exercises Exclusivity Provision of License and Supply Agreement with Horizon Discovery
Abcam extends a pre-existing license and supply agreement with Horizon by exercising an exclusivity provision for the period from July 2017 through June 2018
Product News
Abcam Launches Multiplex miRNA Profiling Assays
Assays use innovative Firefly particle technology to enhance miRNA research
